Invasive cervical cancer in the 1990s
- 1 January 1990
- journal article
- review article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 6 (6) , 359-363
- https://doi.org/10.1002/ssu.2980060612
Abstract
The death rate from invasive cervical cancer has decreased by 70% since the classic work by Papanicolaou and Traut in 1941 on the use of cytologic evaluation to detect cancer of the uterine cervix in the preinvasive in situ stage—a nearly 100% curable disease. Unfortunately, the survival stage for stage of invasive cervical cancer has remained static over the nearly 5 decades since their report. However, discoveries in the decade of the 1970s of the natural spread of cervical cancer, not only to the known pelvic lymph nodes, but the increasing incidence of paraaortic lymph node metastasis with advanced stages, the higher dose of radiation required to sterilize pelvic lymph node metastasis discovered at the time of radical hysterectomy or for locally advanced cervical cancer treated solely by radiation therapy, and the use of radiation potentiators, such as hydroxyurea, should lead to the significant reduction in the annual 7,000 deaths from this disease in the decade of the 1990s.Keywords
This publication has 21 references indexed in Scilit:
- Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancerJournal of Surgical Oncology, 1989
- Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinomaGynecologic Oncology, 1989
- Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancerJournal of Surgical Oncology, 1987
- Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a radiation therapy oncology group randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: An RTOG randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Sensitizers and radiation dose fractionation: Results and interpretationsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The Medical Research Council trial of misonidazole in carcinoma of the uterine cervixThe British Journal of Radiology, 1984
- Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy?: A report from the presidential panel at the 1979 Annual Meeting of the Society of Gynecologic OncologistsGynecologic Oncology, 1980